ATS 2019 Virtual Final Program

10:15 Does Treating Bronchopulmonary Dysplasia (BPD) Associated Pulmonary Hypertension (PH) Improve Survival?/ M. Nyp, M. Norberg, E. Sagaydak, C. Mahajan, W.E. Truog, Kansas City, MO, p.A4265 10:30 High pCO2 Levels at 36 Weeks Is Associated with Longer Duration of Home Oxygen in Infants with Bronchopulmonary Dysplasia (BPD)/ S. Dawson, L. D’Andrea, R. Lau, J. Lagatta, Milwaukee, WI, p.A4266 10:45 Use of Home Oximetry Recording Decreases Duration of Supplemental Oxygen in Premature Infants with Bronchopulmonary Dyslasia/ L.M. Rhein, H.A. Feldman, C. Sheils, T. Hartman, H. White, Worcester, MA, p.A4267 11:00 The Urinary Metabolome and Bronchopulmonary Dysplasia in Preterm Infants Treated with Inhaled Nitric Oxide/ D.G. Torgerson, R. Keller, R. Ballard, P. Ballard, Montreal, Canada, p.A4268 BEHAVIORAL MINI SYMPOSIUM C17 PULMONARY REHABILITATION 2019 9:15 a.m. - 11:15 a.m. KBHCCD Room C146 (Level 1) Chairing: W. Man, MD, PhD, Harefield, United Kingdom Featured Speaker 9:15 Top Two Publications in Pulmonary Rehabilitation 2019/ Speaker to be announced Oral Presentations 9:30 Association Between Pulmonary Rehabilitation Following Hospitalization for COPD and 1-Year Mortality/ P.K. Lindenauer, M.S. Stefan, A. Priya, K.A. Spitzer, Q.R. Pack, T.C. Lagu, P.S. Pekow, V.M. Pinto-Plata, R.L. ZuWallack, Springfield, MA, p.A4269 9:45 Does an Immediate Commencement of Pulmonary Rehabilitation Following Hospitalization for an Exacerbation of Chronic Obstructive Pulmonary Disease Positively Impact Attendance and Completion Rates: A Pilot Randomized Controlled Trial?/ C. Tang, A.M. Southcott, K. Barker, F. Pazsa, E.H. Skinner, F. Blackstock, Penrith, Australia, p.A4270 10:00 Geographic and Racial Disparities in Receipt of Pulmonary Rehabilitation Following Hospital Discharge for COPD Exacerbations/ K.A. Spitzer, M.S. Stefan, A. Priya, P. Pekow, Q.R. Pack, T. Lagu, K. Mazor, V.M. Pinto-Plata, R.L. ZuWallack, P.K. Lindenauer, Springfield, MA, p.A4271 10:15 A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Assess the Effect of Reldesemtiv on Exercise Tolerance in Subjects with Chronic Obstructive Pulmonary Disease/ H.B. Rossiter, R. Casaburi, F.C. Sciurba, J. Porszasz, W.W. Stringer, U. Valluri, M. Kashiwa, S. Tauscher-Wisniewski, Torrance, CA, p.A4272 10:30 Pulmonary Tele-Rehabilitation Versus Conventional Pulmonary Rehabilitation a Multicenter, Single Blinded, Superiority RCT/ H. Hansen, A. Frolich, N. Beyer, T. Bieler, T. Kallemose, N. Godtfredsen, Copenhagen, Denmark, p.A4273 10:45 Internet-Mediated, Pedometer-Based Physical Activity Intervention Reduces Risk of Future Acute Exacerbations in COPD: A Randomized Trial/ E.S. Wan, A. Kantorowski, R. Kadri, C.R. Richardson, D. Gagnon, E. Garshick, M. Moy, Boston, MA, p.A4274 11:00 Influence of Spirometric Impairment on Improvement in Constant Work Rate Cycling Endurance in COPD Patients: Differences in Response to Bronchodilator Therapy and Exercise Training/ R. Casaburi, A.L. Hamilton, D.D. Merrill, G. Harding, R. Yu, N. Locantore, M.A. Spruit, A.J. van ‘t Hul, H.B. Rossiter, F.C. Sciurba, Torrance, CA, p.A4275 BASIC • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM C18 RARE LUNG DISEASES 9:15 a.m. - 11:15 a.m. KBHCCD Room D220/D227 (Level 2) Chairing: F.X. McCormack, MD, Cincinnati, OH E.P. Henske, MD, Boston, MA J.A. Wambach, MD, MS, St. Louis, MO Featured Speaker 9:15 The Bones of Fibrosis/ F.X. McCormack MD, Cincinnati, OH Oral Presentations 9:30 Cre Recombinase-Mediated, Site-Specific Integration for Functional Characterization of ABCA3 Variants/ J.A. Wambach, D.J. Wegner, P. Yang, H.B. Heins, F.S. Cole, St. Louis, MO, p.A4276 9:45 Expression of Distinct Surfactant Protein-C (SFTPC) Mutation Classes Reveal Common Downstream Pathways from Alveolar Type 2 Cell Quality Control Dysfunction to Pulmonary Fibrosis/ J. Katzen, S.-I. Nureki, A. Venosa, Y. Tomer, M. Kopp, B. Wagner, S. Mulugeta, R.R. Deterding, M.F. Beers, Philadelphia, PA, p.A4277 10:00 NEK10 Loss of Function Causes a Novel Human Motile Ciliopathy/ R. Chivukula, H.M. Leung, D. Montoro, A. Waghray, K.E. Black, L.P. Hariri, D.M. Sabatini, G. Tearney, J. Rajagopal, Boston, MA, p.A4278 10:15 NK Cell Activation Is Increased in Lymphangioleiomyomatosis/ M.T. Borchers, M.A. Terry, F.X. McCormack, A. Osterburg, J.J. Yu, A.-K.T. Perl, Cincinnati, OH, p.A4279 10:30 Disruptive Effect of LAM-Derived Smooth Muscle Cells on Human Lung Progenitors Is Dependent on Expression of Translationally Controlled Tumour Protein/ M. Ho, M. Ho, L.M. Julian, W.L. Stanford, D.J. Stewart, Ottawa, Canada, p.A4280 ATS 2019 • Dallas, TX TUESDAY • MAY 21 229 TUESDAY MORNING